-+ 0.00%
-+ 0.00%
-+ 0.00%

According to the Zhitong Finance App, Gacos-B (01167.HK) announced that Beijing Gacos New Drug Development Co., Ltd., a non-wholly-owned subsidiary of the group, and AstraZeneca AB (AstraZeneca) have signed a licensing and cooperation agreement to develop and commercialize the pan-KRAS inhibitor JAB-23E73.

Zhitongcaijing·12/21/2025 12:01:02
Listen to the news
According to the Zhitong Finance App, Gacos-B (01167.HK) announced that Beijing Gacos New Drug Development Co., Ltd., a non-wholly-owned subsidiary of the group, and AstraZeneca AB (AstraZeneca) have signed a licensing and cooperation agreement to develop and commercialize the pan-KRAS inhibitor JAB-23E73.